BeOne Medicines (BEIGF) Operating Margin (2016 - 2025)
Historic Operating Margin for BeOne Medicines (BEIGF) over the last 11 years, with Q3 2025 value amounting to 11.55%.
- BeOne Medicines' Operating Margin rose 235600.0% to 11.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.67%, marking a year-over-year increase of 299800.0%. This contributed to the annual value of 14.91% for FY2024, which is 342100.0% up from last year.
- BeOne Medicines' Operating Margin amounted to 11.55% in Q3 2025, which was up 235600.0% from 6.68% recorded in Q2 2025.
- BeOne Medicines' 5-year Operating Margin high stood at 89.06% for Q4 2021, and its period low was 316.58% during Q2 2021.
- Over the past 5 years, BeOne Medicines' median Operating Margin value was 34.77% (recorded in 2024), while the average stood at 63.67%.
- As far as peak fluctuations go, BeOne Medicines' Operating Margin surged by 7295300bps in 2021, and later tumbled by -2123500bps in 2022.
- BeOne Medicines' Operating Margin (Quarter) stood at 89.06% in 2021, then plummeted by -238bps to 123.29% in 2022, then skyrocketed by 51bps to 60.5% in 2023, then soared by 88bps to 7.04% in 2024, then soared by 264bps to 11.55% in 2025.
- Its last three reported values are 11.55% in Q3 2025, 6.68% for Q2 2025, and 0.99% during Q1 2025.